Systemic lupus erythematosus

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Manson, Jessica J ^a   Rahman, Anisur ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE;

EID: 34248146162     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-6     Document Type: Review

References (22)

1. The 1982 revised criteria for the classification of systemic lupus erythematosus. EM Tan AS Cohen JF Fries AT Masi DJ McShane NF Rothfield JG Schaller N Talal RJ Winchester, Arthritis Rheum 1982 25 1271 1277 7138600
2. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. MC Hochberg, Arthritis Rheum 1997 40 1725 9324032
3. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. R Cervera MA Khamashta J Font GD Sebastiani A Gil P Lavilla JC Mejia AO Aydintug H Chwalinska-Sadowska E de Ramon A Fernandez-Nebro M Galeazzi M Valen A Mathieu F Houssiau N Caro P Alba M Ramos-Casals M Ingelmo GR Hughes European Working Partyon Systemic Lupus Erythematosus, Medicine (Baltimore) 2003 82 299 308 14530779
4. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. AE Johnson C Gordon RG Palmer PA Bacon, Arthritis Rheum 1995 38 551 558 7718010
5. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. MM Ward, J Womens Health (Larchmt) 2004 13 713 718 15333286
6. The pathogenesis of systemic lupus erythematosus. JJ Manson DA Isenberg, Neth J Med 2003 61 343 346 14768716
7. Genetics of human systemic lupus erythematosus: the emerging picture. SK Nath J Kilpatrick JB Harley, Curr Opin Immunol 2004 16 794 800 10.1016/j.coi.2004.09.007 15511675
8. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. RA Asherson R Cervera JC Piette Y Shoenfeld G Espinosa MA Petri E Lim TC Lau A Gurjal A Jedryka-Goral H Chwalinska-Sadowska RJ Dibner J Rojas-Rodriguez M Garcia-Carrasco JT Grandone AL Parke P Barbosa C Vasconcelos M Ramos-Casals J Font M Ingelmo, Medicine (Baltimore) 2001 80 355 377 10.1097/00005792-200111000-00002 11704713
9. The prevalence and associations of fatigue in systemic lupus erythematosus. CM Tench I McCurdie PD White DP D'Cruz, Rheumatology (Oxford) 2000 39 1249 1254 10.1093/rheumatology/39.11.1249 11085805
10. The classification of glomerulonephritis in systemic lupus erythematosus revisited. JJ Weening VD D'Agati MM Schwartz SV Seshan CE Alpers GB Appel JE Balow JA Bruijn T Cook F Ferrario AB Fogo EM Ginzler L Hebert G Hill P Hill JC Jennette NC Kong P Lesavre M Lockshin LM Looi H Makino LA Moura M Nagata, J Am Soc Nephrol 2004 15 241 250 10.1097/01.ASN.0000108969.21691.5D 14747370
11. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 42 599 608 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F 10211873
12. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. JE Jennings PC Sundgren J Attwood J McCune P Maly, Neuroradiology 2004 46 15 21 10.1007/s00234-003-1049-2 14648006
13. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. SM Sultan S Begum DA Isenberg, Rheumatology (Oxford) 2003 42 230 234 10.1093/rheumatology/ keg069 12595615
14. Pulmonary disease in systemic lupus erythematosus and the antiphospholpid syndrome. D Paran E Fireman O Elkayam, Autoimmun Rev 2004 3 70 75 10.1016/S1568-9972(03)00090-9 14871652
15. A review of gastrointestinal manifestations of systemic lupus erythematosus. SM Sultan Y Ioannou DA Isenberg, Rheumatology (Oxford) 1999 38 917 932 10.1093/rheumatology/38.10.917 10534541
16. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. MM Ward, Arthritis Rheum 1999 42 338 346 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U 10025929
17. Treatment for lupus nephritis. RS Flanc MA Roberts GF Strippoli SJ Chadban PG Kerr RC Atkins, Cochrane Database Syst Rev CD002922 14973998
18. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. DT Boumpas HA Austin 3rd EM Vaughn JH Klippel AD Steinberg CH Yarboro JE Balow, Lancet 1992 340 741 745 10.1016/0140-6736(92)92292-N 1356175
19. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. FA Houssiau C Vasconcelos D D'Cruz GD Sebastiani Ed Garrido R Ede MG Danieli D Abramovicz D Blockmans A Mathieu H Direskeneli M Galeazzi A Gul Y Levy P Petera R Popovic R Petrovic RA Sinico R Cattaneo J Font G Depresseux JP Cosyns R Cervera, Arthritis Rheum 2002 46 2121 1231 10.1002/art.10461 12209517
20. Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis. TM Chan FK Li CS Tang RW Wong GX Fang YL Ji CS Lau AK Wong MK Tong KW Chan KN Lai, N Engl J Med 2000 343 1156 1162 10.1056/NEJM200010193431604 11036121
21. An open study of B lymphocyte depletion in systemic lupus erythematosus. MJ Leandro JC Edwards G Cambridge MR Ehrenstein DA Isenberg, Arthritis Rheum 2002 46 2673 2677 10.1002/art.10541 12384926
22. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. KE Moss Y Ioannou SM Sultan I Haq DA Isenberg, Ann Rheum Dis 2002 61 409 413 10.1136/ard.61.5.409 11959764